Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

(2010) E. P. Rhee et al.   Clinical Journal of the American Society of Nephrology

Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial

(2010) P. J. MEASE et al.   JOURNAL OF RHEUMATOLOGY

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies

(2010) Bert Vander Cruyssen et al.   ARTHRITIS RESEARCH & THERAPY

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis

(2008) O Flossmann et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of primary small and medium vessel vasculitis

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

Modulation of molecular imprints in the antigen-experienced B cell repertoire by rituximab

(2008) Arumugam Palanichamy et al.   ARTHRITIS AND RHEUMATISM

Rituximab-induced B cell depletion in autoimmune diseases: Potential effects on T cells

(2008) Stamatis-Nick C. Liossis et al.   CLINICAL IMMUNOLOGY